Published Erratum Ahead of print
PubMed: 42853534 DOI: 10.1007/s12325-026-03813-y
Correction: Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia.
Adv Ther
Authors: Konstantinos Prokopidis, Stefano Cacciatore, Stephen D Anton, John A Batsis
Affiliations
- Department of Musculoskeletal Ageing and Science, Institute of Life Course and Medical Sciences, University of Liverpool, Konstantinos Prokopidis, Liverpool, L7 8TX, UK.
- Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, FL, USA.
- Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Division of Geriatric Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
MeSH
Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor, Drug Therapy, Diagnosis, Therapeutics, Sarcopenia